JP2014501518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501518A5 JP2014501518A5 JP2013543140A JP2013543140A JP2014501518A5 JP 2014501518 A5 JP2014501518 A5 JP 2014501518A5 JP 2013543140 A JP2013543140 A JP 2013543140A JP 2013543140 A JP2013543140 A JP 2013543140A JP 2014501518 A5 JP2014501518 A5 JP 2014501518A5
- Authority
- JP
- Japan
- Prior art keywords
- myumyu
- chelerythrine
- ivermectin
- culturing
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LLEJIEBFSOEYIV-UHFFFAOYSA-N chelerythrine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 claims 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 claims 1
- 229940074360 caffeic acid Drugs 0.000 claims 1
- 235000004883 caffeic acid Nutrition 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 229960002418 ivermectin Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2010/059586 WO2012078153A1 (en) | 2010-12-08 | 2010-12-08 | Agents and methods for inhibiting human pluripotent stem cell growth |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501518A JP2014501518A (ja) | 2014-01-23 |
| JP2014501518A5 true JP2014501518A5 (en:Method) | 2014-03-13 |
| JP5875597B2 JP5875597B2 (ja) | 2016-03-02 |
Family
ID=46207417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013543140A Expired - Fee Related JP5875597B2 (ja) | 2010-12-08 | 2010-12-08 | ヒト万能性幹細胞の成長を阻害する薬剤および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9365830B2 (en:Method) |
| EP (1) | EP2649177B1 (en:Method) |
| JP (1) | JP5875597B2 (en:Method) |
| CN (1) | CN103354835B (en:Method) |
| AU (1) | AU2010365057B2 (en:Method) |
| CA (1) | CA2820419A1 (en:Method) |
| ES (1) | ES2690663T3 (en:Method) |
| WO (1) | WO2012078153A1 (en:Method) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012029611A2 (pt) | 2010-05-21 | 2017-07-25 | Merrimack Pharmaceuticals Inc | proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico |
| CN108220224A (zh) | 2011-06-21 | 2018-06-29 | 诺沃—诺迪斯克有限公司 | 自多潜能干细胞有效诱导定形内胚层 |
| KR102164270B1 (ko) | 2013-03-25 | 2020-10-12 | 고에키 자이단 호징 고베 이료 산교 도시 스이신 기코 | 세포의 선별 방법 |
| CA2913990C (en) * | 2013-05-30 | 2021-10-12 | Ajinomoto Co., Inc. | Medium for culturing stem cells |
| CN105683366B (zh) * | 2013-08-23 | 2020-11-06 | 住友化学株式会社 | 用于制备视网膜组织和视网膜相关细胞的方法 |
| WO2015112581A1 (en) * | 2014-01-21 | 2015-07-30 | The Medical College Of Wisconsin, Inc. | Methods for selective inhibition of pluripotent stem cells |
| WO2015151307A1 (ja) * | 2014-03-31 | 2015-10-08 | 味の素株式会社 | 幹細胞用培地 |
| EP3334820B1 (en) * | 2015-08-13 | 2024-05-15 | Beihao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. | Induced extended pluripotent stem cells, methods of making and using |
| EP3355907B1 (en) | 2015-10-02 | 2021-01-20 | Silver Creek Pharmaceuticals, Inc. | Bi-specific therapeutic proteins for tissue repair |
| US20190018000A1 (en) | 2016-01-12 | 2019-01-17 | Cedars-Sinai Medical Center | A method of non destructive monitoring of biological processes in microfluidic tissue culture systems |
| WO2018140647A1 (en) * | 2017-01-25 | 2018-08-02 | Cedars-Sinai Medical Center | In vitro induction of mammary-like differentiation from human pluripotent stem cells |
| CN110234754B (zh) | 2017-01-27 | 2024-02-20 | 株式会社钟化 | 内胚层细胞团、和由多能细胞制造三胚层中的任意胚层的细胞团的方法 |
| CN110582561A (zh) * | 2017-03-07 | 2019-12-17 | 血小板生源说股份有限公司 | 再循环生物反应器 |
| US11767513B2 (en) | 2017-03-14 | 2023-09-26 | Cedars-Sinai Medical Center | Neuromuscular junction |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| CN110506109B (zh) | 2017-06-05 | 2024-03-12 | 泰尔茂株式会社 | 细胞培养物的制造方法 |
| US10391156B2 (en) | 2017-07-12 | 2019-08-27 | Viacyte, Inc. | University donor cells and related methods |
| CN108570443A (zh) * | 2017-12-05 | 2018-09-25 | 皓昇莱生物制药有限公司 | 一种用于培养尿液来源细胞的培养基 |
| EP3768823B1 (en) | 2018-03-23 | 2025-12-31 | Cedars-Sinai Medical Center | METHODS FOR USING CELLS FROM PANCREATIC ISLETS |
| CN111836884B (zh) * | 2018-03-28 | 2023-07-25 | 国立大学法人大阪大学 | 源自干细胞的泪腺组织的制作方法 |
| US11981918B2 (en) | 2018-04-06 | 2024-05-14 | Cedars-Sinai Medical Center | Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells |
| US12241085B2 (en) | 2018-04-06 | 2025-03-04 | Cedars-Sinai Medical Center | Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip |
| CN110684714B (zh) * | 2018-07-05 | 2023-05-09 | 广东博溪生物科技有限公司 | 一种屏障功能弱化模型的构建方法 |
| US12157872B2 (en) | 2018-07-19 | 2024-12-03 | Stellular Bio, Inc. | Stacked recirculating bioreactor |
| US10724052B2 (en) | 2018-09-07 | 2020-07-28 | Crispr Therapeutics Ag | Universal donor cells |
| WO2020059892A1 (ja) * | 2018-09-19 | 2020-03-26 | 武田薬品工業株式会社 | インスリン産生細胞 |
| WO2020067438A1 (ja) | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
| JP7409670B2 (ja) * | 2018-12-21 | 2024-01-09 | 国立大学法人北海道大学 | 多能性幹細胞を除去するための組成物、及び多能性幹細胞の除去方法 |
| CN110373375A (zh) * | 2019-03-19 | 2019-10-25 | 杭州原生生物科技有限公司 | 一种制备纤维细胞作为细胞培养基的方法和用途 |
| KR20220052370A (ko) | 2019-09-05 | 2022-04-27 | 크리스퍼 테라퓨틱스 아게 | 보편적 공여자 세포 |
| EP4025224A1 (en) | 2019-09-05 | 2022-07-13 | CRISPR Therapeutics AG | Universal donor cells |
| CN116057185A (zh) | 2020-08-15 | 2023-05-02 | 雷杰纳荣制药公司 | 治疗具有编码降钙素受体(calcr)的变体核酸分子的受试者的肥胖症 |
| EP4271795A1 (en) | 2020-12-31 | 2023-11-08 | CRISPR Therapeutics AG | Universal donor cells |
| TW202523836A (zh) * | 2023-12-12 | 2025-06-16 | 佛教慈濟醫療財團法人 | 選擇性去除未分化多潛能幹細胞的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861483A (en) * | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
| IL142748A0 (en) | 1998-11-09 | 2002-03-10 | Univ Monash | Embryonic stem cells |
| US8597947B2 (en) * | 2004-12-29 | 2013-12-03 | Hadasit Medical Research Services & Development Limited | Undifferentiated stem cell culture systems |
| US20080070303A1 (en) * | 2005-11-21 | 2008-03-20 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
| US20120295346A1 (en) * | 2009-07-22 | 2012-11-22 | Tufts University | Methods and compositions for modulating membrane potential to influence cell behavior |
-
2010
- 2010-12-08 CA CA2820419A patent/CA2820419A1/en not_active Abandoned
- 2010-12-08 WO PCT/US2010/059586 patent/WO2012078153A1/en not_active Ceased
- 2010-12-08 CN CN201080071181.7A patent/CN103354835B/zh not_active Expired - Fee Related
- 2010-12-08 ES ES10860584.1T patent/ES2690663T3/es active Active
- 2010-12-08 US US13/992,931 patent/US9365830B2/en not_active Expired - Fee Related
- 2010-12-08 EP EP10860584.1A patent/EP2649177B1/en not_active Not-in-force
- 2010-12-08 AU AU2010365057A patent/AU2010365057B2/en not_active Ceased
- 2010-12-08 JP JP2013543140A patent/JP5875597B2/ja not_active Expired - Fee Related
-
2016
- 2016-06-10 US US15/178,852 patent/US20160281058A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501518A5 (en:Method) | ||
| Langley | Storied landscapes makes us (Modern) Human: Landscape socialisation in the Palaeolithic and consequences for the archaeological record | |
| GB2562396A (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
| JP2013522425A5 (en:Method) | ||
| JP2011526312A5 (en:Method) | ||
| Korobenko et al. | Persistence and extinction in spatial models with a carrying capacity driven diffusion and harvesting | |
| GB2561496A (en) | Devices and methods for simulating a function of a liver tissue | |
| JP2011505522A5 (en:Method) | ||
| BR112012020975A2 (pt) | "método para a construção de bactéria pertencente ao gênero bifidobacterium" | |
| JP2016539641A5 (en:Method) | ||
| BR112015021189A2 (pt) | métodos de banco de células de alta densidade | |
| JP2011519825A5 (en:Method) | ||
| CL2012002871A1 (es) | Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas. | |
| JP2013510355A5 (en:Method) | ||
| WO2013003899A8 (en) | Methods of treating or preventing rheumatic disease | |
| JP2008280345A5 (en:Method) | ||
| CA2847575C (en) | Method for increasing osteoblastic function | |
| WO2011150375A3 (en) | Endothelial colony forming cell culture medium | |
| WO2013022746A3 (en) | Composition containing a polysaccharide hybrid polymer and methods of controlling hard water scale | |
| 高鹏骥 | De novo malignancies after liver transplantation | |
| 刘其金 | A Light Talk on the Phenomena Causing the Changes of the Context in English Listening | |
| 闻玟 | My School Life | |
| 蓝婷 et al. | Some Secrets of Study | |
| 이삼식 | Background and implication of the 2nd basic plan for low fertility and population ageing | |
| 郑志阳 | My Good Friend and I |